When the amyloid precursor protein/presenilin 1 mouse model of Alzheimer’s disease (AD) was subjected to a secondary inflammatory challenge with interleukin-1β (IL-1β), primed astrocytes developed exaggerated chemokine responses [21]. The gene discussed is APP; the disease is Alzheimer disease.